"We continue to strengthen our market leading positions in our electrophysiology and vision businesses while also improving performance in spine and knees in our orthopedics portfolio. Growth was partially offset by declines in our diabetes care business."

"Subsequent to the quarter, we announced the completion of the divestiture of our LifeScan business, which is consistent with our approach to strategic portfolio optimization."

I'm not seeing anything interesting with regards to LifeScan.